We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
GE Healthcare Life Sciences has introduced Biacore 8K+, an eight-needle high-sensitivity surface plasmon resonance (SPR) system that is able to automate over 4500 drug candidate–disease target binding experiments in one run.